vs

Side-by-side financial comparison of Arhaus, Inc. (ARHS) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $364.8M, roughly 1.3× Arhaus, Inc.). Arhaus, Inc. runs the higher net margin — 4.1% vs -10.1%, a 14.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 5.1%). Arhaus, Inc. produced more free cash flow last quarter ($-8.8M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 11.2%).

Arhaus, Inc. is an upscale American home furnishings company headquartered in Boston Heights, Ohio. Founded in 1986 with a focus on sustainability and artisanship in product quality, Arhaus provides a diversified assortment of specialty goods and services addressing omnichannel direct-to-consumer and business-to-business residential and commercial operations.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ARHS vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$364.8M
ARHS
Growing faster (revenue YoY)
CLOV
CLOV
+39.6% gap
CLOV
44.7%
5.1%
ARHS
Higher net margin
ARHS
ARHS
14.2% more per $
ARHS
4.1%
-10.1%
CLOV
More free cash flow
ARHS
ARHS
$60.2M more FCF
ARHS
$-8.8M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
11.2%
ARHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARHS
ARHS
CLOV
CLOV
Revenue
$364.8M
$487.7M
Net Profit
$15.1M
$-49.3M
Gross Margin
38.1%
Operating Margin
5.6%
-10.1%
Net Margin
4.1%
-10.1%
Revenue YoY
5.1%
44.7%
Net Profit YoY
-29.1%
-123.2%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARHS
ARHS
CLOV
CLOV
Q4 25
$364.8M
$487.7M
Q3 25
$344.6M
$496.6M
Q2 25
$358.4M
$477.6M
Q1 25
$311.4M
$462.3M
Q4 24
$347.0M
$337.0M
Q3 24
$319.1M
$331.0M
Q2 24
$309.8M
$356.3M
Q1 24
$295.2M
$346.9M
Net Profit
ARHS
ARHS
CLOV
CLOV
Q4 25
$15.1M
$-49.3M
Q3 25
$12.2M
$-24.4M
Q2 25
$35.1M
$-10.6M
Q1 25
$4.9M
$-1.3M
Q4 24
$21.3M
$-22.1M
Q3 24
$9.9M
$-9.2M
Q2 24
$22.2M
$7.4M
Q1 24
$15.1M
$-19.2M
Gross Margin
ARHS
ARHS
CLOV
CLOV
Q4 25
38.1%
Q3 25
38.7%
Q2 25
41.4%
Q1 25
37.1%
Q4 24
40.0%
Q3 24
38.6%
24.5%
Q2 24
40.1%
30.3%
Q1 24
39.0%
23.6%
Operating Margin
ARHS
ARHS
CLOV
CLOV
Q4 25
5.6%
-10.1%
Q3 25
4.8%
-4.9%
Q2 25
13.0%
-2.2%
Q1 25
1.7%
-0.3%
Q4 24
8.2%
-6.4%
Q3 24
3.3%
-2.7%
Q2 24
9.5%
2.0%
Q1 24
6.2%
-6.5%
Net Margin
ARHS
ARHS
CLOV
CLOV
Q4 25
4.1%
-10.1%
Q3 25
3.5%
-4.9%
Q2 25
9.8%
-2.2%
Q1 25
1.6%
-0.3%
Q4 24
6.1%
-6.6%
Q3 24
3.1%
-2.8%
Q2 24
7.2%
2.1%
Q1 24
5.1%
-5.5%
EPS (diluted)
ARHS
ARHS
CLOV
CLOV
Q4 25
$0.11
Q3 25
$0.09
Q2 25
$0.25
Q1 25
$0.03
Q4 24
$0.15
Q3 24
$0.07
Q2 24
$0.16
Q1 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARHS
ARHS
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$253.4M
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$418.2M
$308.7M
Total Assets
$1.4B
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARHS
ARHS
CLOV
CLOV
Q4 25
$253.4M
$78.3M
Q3 25
$262.2M
Q2 25
$234.8M
Q1 25
$214.4M
Q4 24
$197.5M
$194.5M
Q3 24
$177.7M
$288.0M
Q2 24
$174.2M
$254.8M
Q1 24
$233.2M
$208.3M
Stockholders' Equity
ARHS
ARHS
CLOV
CLOV
Q4 25
$418.2M
$308.7M
Q3 25
$400.4M
$340.9M
Q2 25
$385.6M
$344.2M
Q1 25
$348.8M
$336.1M
Q4 24
$343.7M
$341.1M
Q3 24
$320.6M
$342.2M
Q2 24
$309.3M
$324.9M
Q1 24
$285.6M
$292.5M
Total Assets
ARHS
ARHS
CLOV
CLOV
Q4 25
$1.4B
$541.0M
Q3 25
$1.4B
$559.7M
Q2 25
$1.3B
$575.0M
Q1 25
$1.3B
$583.7M
Q4 24
$1.2B
$580.7M
Q3 24
$1.2B
$653.0M
Q2 24
$1.2B
$674.2M
Q1 24
$1.2B
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARHS
ARHS
CLOV
CLOV
Operating Cash FlowLast quarter
$9.3M
$-66.9M
Free Cash FlowOCF − Capex
$-8.8M
$-69.0M
FCF MarginFCF / Revenue
-2.4%
-14.1%
Capex IntensityCapex / Revenue
5.0%
0.4%
Cash ConversionOCF / Net Profit
0.62×
TTM Free Cash FlowTrailing 4 quarters
$59.0M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARHS
ARHS
CLOV
CLOV
Q4 25
$9.3M
$-66.9M
Q3 25
$46.1M
$12.1M
Q2 25
$34.9M
$5.4M
Q1 25
$46.5M
$-16.3M
Q4 24
$31.7M
$34.8M
Q3 24
$31.1M
$50.0M
Q2 24
$47.5M
$44.8M
Q1 24
$36.8M
$25.9M
Free Cash Flow
ARHS
ARHS
CLOV
CLOV
Q4 25
$-8.8M
$-69.0M
Q3 25
$28.0M
$11.4M
Q2 25
$20.9M
$4.8M
Q1 25
$18.9M
$-16.5M
Q4 24
$13.0M
$33.3M
Q3 24
$4.6M
$49.6M
Q2 24
$11.3M
$44.4M
Q1 24
$10.9M
$25.5M
FCF Margin
ARHS
ARHS
CLOV
CLOV
Q4 25
-2.4%
-14.1%
Q3 25
8.1%
2.3%
Q2 25
5.8%
1.0%
Q1 25
6.1%
-3.6%
Q4 24
3.7%
9.9%
Q3 24
1.4%
15.0%
Q2 24
3.6%
12.5%
Q1 24
3.7%
7.3%
Capex Intensity
ARHS
ARHS
CLOV
CLOV
Q4 25
5.0%
0.4%
Q3 25
5.3%
0.1%
Q2 25
3.9%
0.1%
Q1 25
8.9%
0.0%
Q4 24
5.4%
0.5%
Q3 24
8.3%
0.1%
Q2 24
11.7%
0.1%
Q1 24
8.8%
0.1%
Cash Conversion
ARHS
ARHS
CLOV
CLOV
Q4 25
0.62×
Q3 25
3.77×
Q2 25
1.00×
Q1 25
9.53×
Q4 24
1.49×
Q3 24
3.14×
Q2 24
2.14×
6.04×
Q1 24
2.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARHS
ARHS

Sales Channel Retail$305.7M84%
Sales Channel E Commerce$59.2M16%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons